Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (901-910 of 1,158) with videos related to

Pageof 116
Sort By:
AJR. American Journal of Roentgenology|November 21, 2015
Model-Based Iterative Reconstruction in CT EnterographyKevin P Murphy, Lee Crush, Maria Twomey, et al.
Journal of the American Academy of Dermatology|December 5, 2021
Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomesNeha Gupta, Rachel E Weitzman, Fadi Murad, et al.
Lung|July 17, 2023
Analytic Morphomics in Myositis-Related Interstitial Lung DiseaseAlexander T O'Mahony, Patrick J Henry, Patrick Coghlan, et al.
Surgery, Gynecology & Obstetrics|October 1, 1977
Serum hepatic enzyme and bilirubin elevations during parenteral nutritionJ P Grant, C E Cox, L M Kleinman, et al.
The Lancet. Respiratory Medicine|December 3, 2014
Combination therapy: the future of management for idiopathic pulmonary fibrosis?Wim A Wuyts, Katerina M Antoniou, Keren Borensztajn, et al.
Respirology (Carlton, Vic.)|January 4, 2012
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumoniaTamera J Corte, Stephen J Wort, Peter S MacDonald, et al.
Trials|March 3, 2022
PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis CoughZhe Wu, Winston Banya, Nazia Chaudhuri, et al.
Biochemical and Biophysical Research Communications|September 8, 2009
Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systemsKosuke Okada, Junichi Shoda, Keiko Taguchi, et al.
Respiratory Medicine|July 23, 2013
The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung diseaseAmit S Patel, Richard J Siegert, Gregory J Keir, et al.
Clinical and Experimental Rheumatology|July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.
Pageof 116

Showing results (901-910 of 1,158) with videos related to

Sort By:
Pageof 116
AJR. American Journal of Roentgenology|November 21, 2015
Model-Based Iterative Reconstruction in CT EnterographyKevin P Murphy, Lee Crush, Maria Twomey, et al.
Journal of the American Academy of Dermatology|December 5, 2021
Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomesNeha Gupta, Rachel E Weitzman, Fadi Murad, et al.
Lung|July 17, 2023
Analytic Morphomics in Myositis-Related Interstitial Lung DiseaseAlexander T O'Mahony, Patrick J Henry, Patrick Coghlan, et al.
Surgery, Gynecology & Obstetrics|October 1, 1977
Serum hepatic enzyme and bilirubin elevations during parenteral nutritionJ P Grant, C E Cox, L M Kleinman, et al.
The Lancet. Respiratory Medicine|December 3, 2014
Combination therapy: the future of management for idiopathic pulmonary fibrosis?Wim A Wuyts, Katerina M Antoniou, Keren Borensztajn, et al.
Respirology (Carlton, Vic.)|January 4, 2012
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumoniaTamera J Corte, Stephen J Wort, Peter S MacDonald, et al.
Trials|March 3, 2022
PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis CoughZhe Wu, Winston Banya, Nazia Chaudhuri, et al.
Biochemical and Biophysical Research Communications|September 8, 2009
Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systemsKosuke Okada, Junichi Shoda, Keiko Taguchi, et al.
Respiratory Medicine|July 23, 2013
The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung diseaseAmit S Patel, Richard J Siegert, Gregory J Keir, et al.
Clinical and Experimental Rheumatology|July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.
Pageof 116